Originally Published PMPN
February 2004
NEWS
Valois Acquires New InhalerValois Pharmaceutical Division (Marly-le-Roi, France) has acquired the rights to a dry powder inhaler from Quadrant Technologies Ltd. With this acquisition, the company has expanded its pulmonary franchise.
The device is a multidose inhaler based on a blister-type powder storage system. This system provides advanced moisture protection for the drug and high fine-particle fraction performance. According to Olivier Fourment, president of Valois, the technology complements the firm’s metering valves used for pressurized metered dose inhalers. “It will allow us to strengthen our leading position in pulmonary drug delivery devices and offer pharmaceutical and biotechnology companies a portfolio of technologies to meet their pulmonary drug delivery needs,” he said.
Valois has also secured the services of Quadrant Drug Delivery for the development of dry powder formulations suitable for the inhaler.
Copyright ©2004 Pharmaceutical & Medical Packaging News
